Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.45 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 5/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4990203 | 1.00 | NAAA (0.52) | NAAATSHRHCAR2RAD52NPSR1 | |
| Ammonia Solution, Strong SCHEMBL27509345 | 0.92 | TSHR (0.50) | NAAATSHRHCAR2RAD52NPSR1 | |
| SCHEMBL8858229 | 0.88 | TSHR (0.50) | NAAATSHRHCAR2RAD52NPSR1 | |
| SCHEMBL8858232 | 0.88 | TSHR (0.50) | NAAATSHRHCAR2RAD52NPSR1 | |
| SCHEMBL5143635 | 0.88 | NAAA (0.53) | NAAATSHRHCAR2RAD52NPSR1 | |
| SCHEMBL28160102 | 0.85 | TSHR (0.50) | NAAATSHRHCAR2RAD52NPSR1 | |
| SCHEMBL2228694 | 0.84 | NAAA (0.57) | NAAATSHRHCAR2RAD52NPSR1 | |
| SCHEMBL2228697 | 0.84 | NAAA (0.57) | NAAATSHRHCAR2RAD52NPSR1 | |
| Ammonia Solution, Strong SCHEMBL27608605 | 0.84 | HCAR2 (0.37) | NAAATSHRHCAR2ALDH1A1LMNA | |
| SCHEMBL27672923 | 0.83 | TSHR (0.49) | NAAATSHRHCAR2RAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200368131-A1 | OIL-BASED COMPOSITION | POLA CHEM IND INC (JP) | 2020-11-26 | — | — | US | disclosed |
| EP-3711746-A1 | OIL-BASED COMPOSITION | Pola Chemical Industries Inc. (JP) | 2020-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200368131-A1 | OIL-BASED COMPOSITION | CUTA, EBP, LIPA | NAAA 2350/4885TSHR 4625/4885HCAR2 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.